Extensive research efforts have been focused on EGFR over the past two decades and anti-EGFR therapy in combination with conventional chemotherapy is now in routine practice for cancers such as metastatic colorectal cancer (mCRC) [96]. This evidence concerns the gene EGFR and cancer.